Dr. Andrew Cluster, M.D.
Claim this profileWashington University School of Medicine
Studies Brain Tumor
Studies Cerebral Gliomas
18 reported clinical trials
29 drugs studied
About Andrew Cluster, M.D.
Education:
- Received an MD from Washington University School of Medicine.
Experience:
- Serves as a Pediatric Oncologist at Washington University Physicians, specializing in oncology and pediatric cancer.
- Affiliated with St. Louis Children's Hospital, recognized as a leading pediatric hospital.
- Active member of the Siteman Cancer Center, focusing on innovative pediatric cancer treatments and clinical trials.
- Engaged in the Cancer Predisposition Program to identify and monitor genetically at-risk children.
- Collaborates across multiple specialties including the Melanoma and Nevus Clinic, Stem Cell Transplant and Cellular Therapy Program, and Brain Tumor and Neuro-Oncology Program.
Area of expertise
1Brain Tumor
NTRK positive
Stage I
Stage II
2Cerebral Gliomas
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Andrew Cluster, M.D. is currently running
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
Memory-like NK Cell Therapy
for Acute Myeloid Leukemia
Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one of the most widely used treatment approaches in patients who relapse after allogeneic hematopoietic cell transplant (allo-HCT). However, the complete remission (CR) rates and long term survival remain very poor in these patients and, therefore, there is an unmet need to develop more effective treatment approaches in patients who relapse after allo-HCT. Based on the initial promising results with our ongoing cytokine-induced memory-like (CIML) natural killer (NK) cell trial, the investigators hypothesize that combining the CIML NK cells with DLI approach will significantly enhance the graft versus leukemia and therefore potentially provide potentially curative therapy for these patients with otherwise extremely poor prognosis. Combining CIML NK cells with the DLI platform will also potentially allow these adoptively transferred cells to persist for longer duration as they should not be rejected by donor T cells as the CIML NK cells are derived from the same donor. The use of CIML NK cells is unlikely to lead to excessive graft versus host disease (GVHD) as previous studies have not been associated with excessive GVHD rates.
Recruiting1 award Phase 1 & 2
More about Andrew Cluster, M.D.
Clinical Trial Related5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Andrew Cluster, M.D. has experience with
- Radiation Therapy
- ONC201
- Selumetinib
- Cyclophosphamide
- Lomustine
- Vincristine
Breakdown of trials Andrew Cluster, M.D. has run
Brain Tumor
Cerebral Gliomas
Brain Cancer
Medulloblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Cluster, M.D. specialize in?
Andrew Cluster, M.D. focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved NTRK positive patients, or patients who are Stage I.
Is Andrew Cluster, M.D. currently recruiting for clinical trials?
Yes, Andrew Cluster, M.D. is currently recruiting for 10 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Andrew Cluster, M.D. has studied deeply?
Yes, Andrew Cluster, M.D. has studied treatments such as Radiation Therapy, ONC201, Selumetinib.
What is the best way to schedule an appointment with Andrew Cluster, M.D.?
Apply for one of the trials that Andrew Cluster, M.D. is conducting.
What is the office address of Andrew Cluster, M.D.?
The office of Andrew Cluster, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.